CD274 and breast carcinoma: Many scholars have put forward their own views on the underlying mechanisms governing PDL1 expression during EMT progression: firstly, TGF-β, the primary inducer of EMT, boosts the expression of PDL1 via the PI3K/AKT and MEK/ERK pathways in breast cancer.